Sterile Injectable Contract Manufacturing Market Share

Statistics for the 2023 & 2024 Sterile Injectable Contract Manufacturing market share, created by Mordor Intelligence™ Industry Reports. Sterile Injectable Contract Manufacturing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Sterile Injectable Contract Manufacturing Industry

The sterile injectable contract manufacturing market is consolidated and consists of a few major players. In terms of market share, certain major players currently dominate the market. Market players adopt various strategies such as expanding manufacturing facilities, collaborating, and partnering to stay competitive. Some of the companies currently dominating the market are Baxter, Catalent Inc., Vetter Pharma, Recipharm AB, and Aenova Group.

Sterile Injectable Contract Manufacturing Market Leaders

  1. Baxter

  2. Catalent, Inc

  3. Vetter Pharma

  4. Recipharm AB

  5. Aenova Group

*Disclaimer: Major Players sorted in no particular order

Sterile Injectable Contract Manufacturing Market Concentration

Sterile Injectable Contract Manufacturing Market Size & Share Analysis - Growth, Trends, and Forecasts (2024 - 2029)